🇺🇸 FDA

Drug profile · INN

ketorolac tromethamine

ACULAR LS

approved
US status
approved
Patents linked
8
News articles
0

Quick answer

ketorolac tromethamine (ACULAR LS) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: nasal. Current US regulatory status: approved.

Key facts

INN ketorolac tromethamine
Brand ACULAR LS
Route NASAL
Formulation SOLUTION
Originator Amphastar France Pharmaceuticals

Related patents

Search patents →

  1. US 12344842

    Compositions and methods for treating and preventing macular degeneration

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12116622

    Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12097188

    Compositions and methods for the treatment of macular degeneration

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12084515

    Compositions and methods for treatment of diabetic macular edema

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11969401

    Compositions and methods for treating or limiting development of age-related macular degeneration

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11769597

    Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11519020

    Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF

    Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11046785

    Compositions and methods for treatment of diabetic macular edema

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is ketorolac tromethamine?

ketorolac tromethamine (ACULAR LS) is an FDA-listed pharmaceutical active ingredient. Associated with Amphastar France Pharmaceuticals. Route of administration: nasal. Current US regulatory status: approved.

What is the brand name for ketorolac tromethamine?

ACULAR LS is a marketed brand name for ketorolac tromethamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ketorolac tromethamine?

ketorolac tromethamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.